Cargando…
A meta-analysis of neurogenic exosomes in the diagnosis of Alzheimer's disease
BACKGROUND: Alzheimer's disease (AD) is an irreversible and difficult-to-treat neurodegenerative disease. It is necessary to search for reliable biomarkers for the early diagnosis of AD in a timely and effective manner in high-risk or preclinical AD populations. Studies have shown that neurogen...
Autores principales: | Zhang, Xin, Liu, Huiyu, Huang, Yuanyuan, Wang, Ruimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560781/ https://www.ncbi.nlm.nih.gov/pubmed/37817991 http://dx.doi.org/10.1016/j.heliyon.2023.e20604 |
Ejemplares similares
-
Exosomes in Pathogenesis, Diagnosis, and Treatment of Alzheimer’s Disease
por: Jiang, Liqun, et al.
Publicado: (2019) -
Exosomes as Novel Regulators of Adult Neurogenic Niches
por: Bátiz, Luis Federico, et al.
Publicado: (2016) -
Hippocampal neurogenesis and pro‐neurogenic therapies for Alzheimer's disease
por: Zheng, Jie
Publicado: (2022) -
Neurogenic Traditional Chinese Medicine as a Promising Strategy for the Treatment of Alzheimer’s Disease
por: Sreenivasmurthy, Sravan Gopalkrishnashetty, et al.
Publicado: (2017) -
Resveratrol, Metabolic Dysregulation, and Alzheimer’s Disease: Considerations for Neurogenerative Disease
por: Yang, Alex J. T., et al.
Publicado: (2021)